Apexigen Performance
| APGNDelisted Stock | USD 0.43 0.01 2.27% |
The firm shows a Beta (market volatility) of 0.69, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Apexigen's returns are expected to increase less than the market. However, during the bear market, the loss of holding Apexigen is expected to be smaller as well. Apexigen right now shows a risk of 0.0%. Please confirm Apexigen potential upside, rate of daily change, and the relationship between the sortino ratio and skewness , to decide if Apexigen will be following its price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Apexigen has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, Apexigen is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 23.4 M |
Apexigen |
Apexigen Relative Risk vs. Return Landscape
If you would invest 43.00 in Apexigen on August 24, 2024 and sell it today you would earn a total of 0.00 from holding Apexigen or generate 0.0% return on investment over 90 days. Apexigen is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Apexigen, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Apexigen Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Apexigen's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Apexigen, and traders can use it to determine the average amount a Apexigen's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| APGN |
Based on monthly moving average Apexigen is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Apexigen by adding Apexigen to a well-diversified portfolio.
Apexigen Fundamentals Growth
Apexigen Stock prices reflect investors' perceptions of the future prospects and financial health of Apexigen, and Apexigen fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Apexigen Stock performance.
| Return On Equity | -15.98 | |||
| Return On Asset | -0.89 | |||
| Current Valuation | 205.33 K | |||
| Shares Outstanding | 24.86 M | |||
| Price To Book | 2.32 X | |||
| EBITDA | (32.58 M) | |||
| Cash And Equivalents | 21.62 M | |||
| Cash Per Share | 1.01 X | |||
| Total Debt | 106 K | |||
| Debt To Equity | 0.05 % | |||
| Book Value Per Share | (0.09) X | |||
| Cash Flow From Operations | (30.69 M) | |||
| Earnings Per Share | (1.71) X | |||
| Total Asset | 22.86 M | |||
| Retained Earnings | (176.79 M) | |||
About Apexigen Performance
By examining Apexigen's fundamental ratios, stakeholders can obtain critical insights into Apexigen's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Apexigen is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Apexigen Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody therapeutics for oncology. The company was founded in 2010 and is based in San Carlos, California. Apexigen operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 22 people.Things to note about Apexigen performance evaluation
Checking the ongoing alerts about Apexigen for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Apexigen help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Apexigen is not yet fully synchronised with the market data | |
| Apexigen has some characteristics of a very speculative penny stock | |
| Apexigen has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (32.07 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Apexigen currently holds about 21.62 M in cash with (30.69 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.01, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing Apexigen's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Apexigen's stock is overvalued or undervalued compared to its peers.
- Examining Apexigen's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Apexigen's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Apexigen's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Apexigen's stock. These opinions can provide insight into Apexigen's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Consideration for investing in Apexigen Stock
If you are still planning to invest in Apexigen check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Apexigen's history and understand the potential risks before investing.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |